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Abstract.  Niemann-Pick disease type C  (NPC) is 
characterized by substantial  intracellular accumulation 
of unesterified cholesterol.  The accumulation of un- 
esterified cholesterol in NPC fibroblasts cultured with 
low density lipoprotein (LDL) appears to result from 
the inability of LDL to stimulate cholesterol es- 
terification in addition to impaired LDL-mediated 
downregulation of LDL receptor activity and cellular 
cholesterol synthesis. Although a defect in cholesterol 
transport in NPC cells has been inferred from previ- 
ous studies, no experiments have been reported that 
measure the intracellular  movement of LDL- 
cholesterol specifically. We have used four approaches 
to assess intracellular cholesterol transport in normal 
and NPC cells and have determined the following: (a) 
mevinolin-inhibited  NPC cells are defective in using 
LDL-cholesterol for growth.  However, exogenously 
added mevalonate restores cell growth equally in nor- 
mal and NPC cells;  (b) the transport of LDL-derived 
[3H]cholesterol to the plasma membrane is slower in 
NPC cells, while the rate of appearance of [3H]acetate- 
derived, endogenously synthesized [3H]cholesterol at 
the plasma membrane is the same for normal and 
NPC cells; (c) in NPC cells, LDL-derived [3H]choles- 
terol accumulates in lysosomes to higher levels than 
normal,  resulting in defective movement to other cell 
membranes; and (d) incubation of cells with LDL 
causes an increase in cholesterol content of NPC lyso- 
somes that is threefold greater than that observed in 
normal  lysosomes. Our results indicate that a choles- 
terol transport defect exists in NPC that is specific for 
LDL-derived cholesterol. 
M 
AMMALIAN cells require  cholesterol  for growth. 
When cultured in the presence of serum, cells ac- 
quire cholesterol  by receptor-mediated endocyto- 
sis of low density lipoprotein  (LDL) l (8).  LDL is delivered 
to  lysosomes where  the  protein/phospholipid  coat is  de- 
graded,  and LDL-cholesteryl esters are hydrolyzed  to un- 
esterified  cholesterol.  LDL-derived cholesterol  is used by 
cells to synthesize  cellular membranes, bile acids,  and ste- 
roid hormones (8). LDL-derived cholesterol also elicits sev- 
eral regulatory responses, including  suppression of choles- 
terol  biosynthesis and  LDL  receptor  activity,  as  well  as 
activation  of the cholesterol-esterifying  enzyme, acyl coen- 
zyme A/cholesterol acyl transferase  (ACAT) (8).  The pro- 
cess of receptor-mediated internalization  of LDL and the 
effects of LDL-cholesterol on cellular cholesterol  metabo- 
lism have been extensively studied (8); however, little infor- 
mation is known about the  fate of cholesterol  formed by 
lysosomal hydrolysis of LDL-cholesteryl esters.  In particu- 
lar, the pathway and mechanism of intracellular  transport of 
LDL-cholesterol from lysosomes to cellular membranes are 
obscure. In addition,  it is not known whether the regulatory 
1. Abbreviations used in this paper:  ACAT, acyl coenzyme A/cholesterol 
acyl transferase;  LDL, low density  lipoprotein;  [3H-CL]LDL,  LDL la- 
beled with  [3H]cholesteryl  linoleate;  NABG, N-acetyl-/~-o-glucosamini- 
dase;  NPA, Niemann-Pick  disease  type A; NPC,  Niemann-Pick  disease 
type C; SUV, small unilamellar  vesicle. 
actions of LDL-cholesterol require either the transport of 
cholesterol to regulatory sites within cells or metabolic trans- 
formation  of the sterol. 
Somatic  cells exhibiting  specific defects in LDL metab- 
olism may be useful in delineating  the mechanisms  of intra- 
cellular transport of and regulation  by LDL-cholesterol. A 
defect in LDL-cholesterol metabolism in fibroblasts from pa- 
tients with Niemann-Pick disease type C (NPC) has been de- 
scribed by Pentchev and co-workers (25-27) and our labora- 
tory (21). Although LDL is bound and internalized,  and the 
cholesteryl esters hydrolyzed normally in NPC fibroblasts, 
LDL-derived cholesterol  does not elicit normal  regulatory 
responses (21, 25-27). In NPC cells, LDL does not stimulate 
cholesterol  esterification,  and  LDL suppression  of choles- 
terol synthesis and LDL receptor activity is impaired (21, 25, 
27). The defective regulation of cellular cholesterol  metabo- 
lism in NPC cells appears to be specific for LDL-derived 
cholesterol,  since 25-hydroxycholesterol,  a nonlipoprotein 
effector, does stimulate  cholesterol  esterification  as well as 
downregulate cholesterol synthesis and LDL receptor activ- 
ity normally in NPC cells (21). Also, exogenously  added 
mevalonate suppresses cholesterol  synthesis equally well in 
normal and NPC cells (21). 
One possible explanation  for the lack of LDL-mediated 
regulation of cholesterol metabolism in NPC cells is that the 
intracellular  transport of cholesterol is defective (21, 27, 32). 
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cholesterol transport  in normal and NPC  fibroblasts.  We 
have measured (a) the ability of LDL-derived and endoge- 
nously synthesized cholesterol to support cell growth; (b) the 
intracellular movement of LDL-derived and endogenously 
synthesized cholesterol; (c) the transfer of LDL-derived cho- 
lesterol from lysosomes to other cell membranes; and (d) 
cholesterol content of lysosomes and cell membranes from 
cells incubated with LDL. 
We found that the movement of LDL-derived cholesterol 
from lysosomes to other cell membranes is impaired in NPC 
cells, while the movement of endogenously synthesized cho- 
lesterol is normal. The finding that NPC fibroblasts express 
a defect in LDL-derived cholesterol transport provides us 
with a valuable tool with which to study intracellular choles- 
terol movement. 
Materials and Methods 
[l,2,6,7-3H]Cholesteryl  linoleate (97.1 Ci/mmol), [4-14C]cholesterol  (53.2 
mCi/mmol),  and  sodium  [3Hlacetate  (100  mCi/mmol)  were  purchased 
from DuPont-New England Nuclear (Boston, MA). Mevinolin was a gift of 
A. Alberts, Merck Research Laboratory (Rahway, NJ). M. Krieger, Biology 
Department, Massachusetts Institute of Technology, generously supplied us 
with  human  lipoprotein-deficient serum  and  LDL.  A  specific inhibitor 
of ACAT, 58-035  (3-[decyldimethylsilyl]-N-12-(4-methylphenyl)-l-phenyl- 
ethyl]propanamide), was provided by Sandoz Inc. (E. Hanover, N J). Percoll 
was obtained from Pharmacia Fine Chemicals (Piscataway, N J). Cholesterol 
(recrystallized from ethanol three times before use) and stigmasterol were 
obtained from Steraloids, Inc. (Wilton, NH). L-a-phosphatidylcholine  from 
fresh egg yolk and all other reagents were from Sigma Chemical Co. (St. 
Louis, MO) or obtained as previously described (21). 
Preparation of  LDL, Lipoprotein-Deficient  Serum, 
and LDL Labeled with [~HICholesteryl Linoleate 
([3H-CLILDL) 
LDL was prepared by ultracentrifugation (16).  Fetal bovine lipoprotein- 
deficient serum was prepared from FBS omitting the thrombin incubation 
(16). [3H-CL]LDL was prepared with an average specific activity of 18,400 
cpm/nmol of total  cholesteryl linoleate in LDL (13). 
Preparation of  Media and Buffers 
The following media were prepared: medium A (MEM supplemented with 
10%  [vol/vol]  FBS, 2 mM glutarniue,  100 units/ml penicillin, 100 ttg/ml 
streptomycin,  I%  [vol/volJ  each of essential amino  acids,  nonessential 
amino acids and vitamins, and 20 mM Hepes, pH 7.3); medium B (medium 
A in which 10% [vol/vol]  FBS is replaced with 10%  [vol/vol]  fetal bovine 
lipoprotein-deficient serum);  and medium C  (medium A  in which  10% 
[vol/vol]  FBS is replaced with 10%  [vol/vol]  human lipoprotein-deficient 
serum). 
The following buffers were prepared: buffer A (150 mM NaCl, 50 mM 
Tris-chloride, pH 7.4);  buffer B (buffer A containing 2 mg/ml BSA); and 
buffer C  (250 mM sucrose,  1 mM EDTA). 
Cultured Cells 
Normal (GM 5659),  NPC (GM 3123),  and Niemann-Pick type A (NPA) 
(GM 0112) fibroblasts were obtained from the Human Mutant Cell Reposi- 
tory (Camden, NJ) and grown as described previously (21) in medium A. 
Experiments were carried out using one of three formats. 
Format  I.  On  day  0,  cells  were  seeded  into  12-well  plates  (5,000 
cells/22.6-mm well) in 1 ml of medium B. 
Format 2. On day 0, cells were seeded into 6-well plates (40,000 cells/35 
mm well) in 1.5 ml of medium B. On day 2, medium was replaced with 1 
ml of medium B. 
Format 3.  On day 0,  cells were seeded into 150-mm dishes (200,000- 
300,000  cells/dish) in 15 ml of medium A. On day 2 or 3, monolayers were 
washed with 15 ml of Earle's balanced salt solution and refed with 15 ml 
of medium B. 
Cell Growth 
Cells were grown according to Format 1. On day 1, monolayers were refed 
with 1.5 ml of medium B or medium B containing 20 ~M mevinolin, 0.15 
mM mevalonate plus various amounts of LDL or additional mevalonate. At 
the same time, 1,5 ml of medium B was added to each well of another 12- 
well plate containing no cells in which a BSA standard curve was performed 
during the Lowry determination. On day 8, wells were washed once quickly, 
three times (10 min, 20°C), and once quickly with buffer A. The residual 
liquid in the wells was completely aspirated, and additions of BSA (0-30 
ttg) were made to wells of  the "no cell/standard curve" plate. Cell-associated 
protein was dissolved with 1 ml of Lowry reagent. Protein was measured 
directly in the wells by the Lowry method (22). Cell growth is expressed 
as microgram of cell protein per well. 
Movement of  Cholesterol to the Plasma Membrane 
To prepare small unilamellar vesicles (SUV) cholesterol (160  p.mol) and 
L-ct-phosphatidylcholine  (232 p.mol) were dried (37°C, N2) and lyophilized 
(2). The lipid sample was dispersed in 4 ml of PBS and sonicated (1 h, 4°C) 
under N2 using a sonifier at setting 3 (model 185; Branson Sonic Power 
Co., Danbury, CT). The dispersion was centrifuged (12,000  g, 5 rain) to 
remove titanium that was shed by the probe, stored at 40C, and used within 
3d. 
Cells were grown according to format 2. On day 4, monolayers were re- 
fed I ml of either (a) medium C plus 20 #M mevinolin, 1/xg/rn158-035,  and 
30 tLg/ml [3H-CLILDL, or (b) medium C containing 15 t~Ci/ml [3H]ace- 
tare. LDL will stimulate cholesterol esterification in normal, but not NPC 
cells (21, 25). To negate any differential effect that cholesterol esterification 
may have on intracellular transport of LDL-cholesterol within the two cell 
lines, ACAT was inhibited in both cell types by the addition of 58-035.  Simi- 
larly, mevinolin was included to negate unequal LDL-mediated suppression 
of cholesterol synthesis in normal and NPC cells (21). After 2 h, monolayers 
were washed with 3 ml of Earle's balanced salt solution and refed with 1 ml 
of medium C plus 50 #l SUVs (containing 2 ~tmol cholesterol and 2.9 ~mol 
L-c~-phosphatidylcholine). 
Cells were harvested at staggered times. Media were removed and cen- 
trifuged (12,000 g, 5 min, 4°C). Ethanol (1 ml) was added to media from 
cells incubated with [3H-CL]LDL.  Media from [3H]acetate-labeled ceils 
were saponified to facilitate the separation of [3H]cholesterol from other 
[3H]acetate-derived products. Each sample received 1 ml of 25% (wt/vol) 
KOH in ethanol and was heale.d (80°C, 1 h). All media samples were then 
extracted twice with 2 ml of petroleum ether. Pooled petroleum ether ex- 
tracts were backwashed with  1 ml of water, and evaporaled to dryness. 
[3HlCholesterol and  [3Hlcholesteryl ester were separated by TLC  using 
toluene/ethyl  acetate  (2:1)  for  [3H-CLILDL-labeled  samples  and  hep- 
tane/ethyl ether (95:55) for [3Hlacetate-labeled samples. 
Cell monolayers were washed once quickly, two times (7 min, 4°C) with 
3 ml of buffer B, and two times quickly with buffer A. All monolayers were 
extracted with hexane/isopropyl alcohol (3:2).  The [3H-CL]LDL-Iabeled 
cell extracts were subjected to TLC (21). [3H]Acetate-labeled cell extracts 
were saponified, extracted, and subsequently subjected to TLC as described 
above for the media samples. Cellular protein on the dishes was dissolved 
in 0.1 N NaOH, and an aliquot taken for Lowry protein determination (22). 
13HlCholesteryl  ester  and  [3H]cholesterol  content  are  expressed  as 
nmol/mg cell protein or pmol/mg cell protein for [3H-CLILDL and [3H]- 
acetate-labeled cells, respectively.  The endogenously synthesized [3HJsterol 
was identified as [3Hlcholesterol by cochromatography with [14Clcholes- 
terol and authentic unlabeled cholesterol. [14C]Cholesterol  (2,000 cpm, 40 
~g) and cholesteryl oleate (20 ~g) were added as chromatography standards 
and to correct for procedural losses (averaging 35%). 
Percoll Gradient Fractionation of  [~H-CL]LDL-labeled 
Fibroblasts 
Ceils were grown according to format 3. On day 4 or 5, monolayers were 
incubated with [3H-CL]LDL in  15 ml of medium C. 
Pulse-chase Protocol (Figs. 4-7).  At staggered times, cells were pulse 
labeled with 5  p.g/ml  [3H-CL]LDL for  1 h.  The  monolayers were then 
washed twice quickly (20°C) with 15 ml of Earle's balanced salt solution 
containing 20 mg/ml BSA, refed with 15 ml of medium C, and replaced in 
the CO2 incubator for various chase times. 
Conanuous  Label Protocol (Fig.  8).  Additions of 2  ~g/ml [3H-CL]- 
LDL were made at staggered times. 
All dishes were harvested at the same time. Media were removed and 
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in 4 ml of water followed by 4 ml of ethanol and extracted twice with 8 ml 
of petroleum ether.  The  combined petroleum ether extracts were back- 
washed with 2 ml of water and evaporated to dryness. [3H]Cholesterol and 
[3H]cholesteryl ester  were  isolated by TLC  using toluene/ethyl acetate 
(2:1).  The monolayers were washed once quickly and once (7 min, 4°C) 
with 15 ml of buffer B, once (7 rain, 4°C) with 15 ml of buffer A, then once 
quickly and once (7 min, 4°C) with 15 ml buffer C. Cells were scraped, 
pelleted by centrifugation (2000 g, 5 min, 4°C), disrupted in 1 ml of buffer 
C  by 2  strokes in a 2-ml tight-fitting Dounce tissue grinder (Kontes Co., 
Vineland, NJ). The homogenates were centrifuged (2000 g, 5 min, 4°C), 
and the pellets were resuspended in buffer C (600 #1), rehomogenized, and 
centrifuged again. The 2,000-g pellets were resuspended in buffer C (600 
#1). The resulting postnuclear supernatants were combined (1.5 ml total), 
and  1 ml (100-180/zg total  cell protein) was layered onto 9  ml of 7.8% 
(vol/vol) Percoll in buffer C.  Gradients were subjected to centrifugation 
(20,000 g, 40 rain, 4°C) in a rotor, (model Ti50, Beckman Instruments, Inc., 
Palo Alto, CA) then fractionated into 10 equal portions. A reference gra- 
dient was developed simultaneously by loading 1 ml of buffer C onto 9 ml 
of 7.8%  Percoll and centrifuging with the samples. 
Cell Fractionation Assays 
Aliquots (200-500/~1)  of  postnuclear supernatants, 2,000-g  pellets, and gra- 
dient fractions were assayed for [3H]cholesteryl ester and [3H]cholesterol 
content following Bligh and Dyer extraction (5).  To facilitate phase separa- 
tion, additional CHCI3 (1.5 vol) and water (1.5 vol) were added to gradient 
samples that contained high concentrations of Percoll. Following centrifu- 
gation,  the organic phases were dried with air,  and  [3H]cholesterol and 
[3H]cholesteryl ester were separated by TLC  using toluene/ethyl acetate 
(2:1).  [3H]Cholesteryl ester and [3H]cholesterol content in the cells (sum of 
postnuclear supernatant and 2,000-g pellet) and  media are expressed as 
nmol/mg protein. [3H]Cholesterol content in the gradient fractions are ex- 
pressed as pmol/fraction. [14C]Cholesterol  (2,000 cpm, 40/zg) and choles- 
teryl oleate (20/zg) were added at the time of extraction as chromatography 
standards and to correct for procedural losses (averaging 26%). Protein was 
measured in postnuclear supernatants and 2,000-g pellets by a Lowry assay 
(22). Densities of gradient fractions derived from a reference Percoll gra- 
dient were measured with a  refractometer (Bausch &  Lomb Inc., Roch- 
ester, NY). 
N-acetyl-/3-glucosaminidase (NABG)  activity was measured in 49 mM 
sodium citrate, pH 4.5, 77 mM KCI, 0.033%  (vol/vol) Triton X-100 with 
2.4 mM p-nitrophenyl N-acetyl-/~-D-glucosaminide  in a final volume of 750 
#1 (3).  After 30 min at 37°C, the reaction was stopped by the addition of 
500 #1 of 0.4 M glycine, pH 10.4. The absorbance of releasedp-nitrophenol 
was measured at 420 nm and compared to the absorbance ofp-nitrophenol 
standards (5-100 nmol). Parallel incubations were performed with aliquots 
of the reference (no cell extract) gradient fractions, and the absorbance due 
to Percoll was subtracted from the experimental values. One unit of NABG 
activity represents the formation of 1 nmol of p-nitrophenol/30 min. 
5' nucleotidase activity was measured in 36 mM Tris, pH 8.5,  8 mM 
MgCI2,  0.10%  (vol/vol) Triton X-100, and 2.3 mM 5'-AMP in a final vol- 
ume of I ml (36). After 60 min at 37°C, 200 #1 of 30% TCA was added, 
and the samples were centrifuged (12,000  g, 5 min). An aliquot (400 ~1) 
of the supernatant was added to 1 ml of Ames reagent (1). After 60 rain at 
37°C, the ahsorbance at 820 nm was determined. Liberated Pi was quanti- 
tated with standards (2.5-40 nmol) that were reacted with the Ames reagent. 
One unit of 5'-nucleotidase activity represents the formation of 1 nmol of 
Pi/60 rain. 
Cholesterol Content of Subcellular Fractions 
Cells were grown according to format 3. Monolayers were harvested accord- 
ing to the procedure for Percoll gradient fractionation (see above) except 
that dishes were washed 3  x  7 min with buffer B. Cell pellets derived from 
two 150-ram  dishes were pooled before the Dounce homogenization. Per- 
coil gradient fractions displaying the highest 5' nucleotidase (fractions 3-5) 
and NA~G (fractions 9-10) activities were pooled to obtain light membranes 
and lysosomes, respectively, and centrifuged (100,000 g, 90 rain) to pellet 
the Percoll (methodology booklet No. 19, Pharmacia Fine Chemicals). Ali- 
quots of the light membrane and lysosome supernatants were lyophilized and 
subjected to Folch extraction (15). Aliquots of postnuclear supernatants were 
Folch-extracted directly.  The unesterified cholesterol content was deter- 
mined after separation by gas-liquid chromatography using a  3%  OV-17 
on 80/100  Gas Chrom Q column (6 feet by 0.085  inch, internal diameter) 
(AIItech Associates, Inc., Deerfield, IL) and quantitated using a flame ion- 
ization detector. Stigmasterol was added to each sample before the Folch 
extraction as an internal standard. Aliquots of the postnuclear supernatants 
were taken for measurement of protein, 5' nucleotidase activity, NAI3G ac- 
tivity,  and cholesterol content. Aliquots of light membrane and lysosome 
supernatant were taken for measurement of 5' nucleotidase and NA/3G ac- 
tivities,  respectively, and  cholesterol content. The  specific activities of 
NA/3G and 5' nucleotidase were the same in postnuclear supernatants of 
normal and NPC cells incubated in the absence and presence of LDL (see 
Table  I). 
Table L LDL-induced Increase in Cholesterol Content of Postnuclear Supernatants and Lysosomal and 
Light Membrane Percoll Gradient Fractions from Normal and NPC Cells 
Normal  Cells  NPC Cells 
Fold  Fold 
- LDL  + LDL  increase  - LDL  + LDL  increase 
(a)  (b)  (b/a)  (a)  (b)  (b/a) 
Postnuclear supernatants 
Protein (#g)  365  368 
5' Nucleotidase activity (U/#g)  19.3  18.2 
NA~G activity (U//zg)  12.0  10.4 
Cholesterol (pmol/ttg)  110  240  2.2 
Light Membranes 
5' Nucleotidase activity (U)  1,608  2,043 
Cholesterol 
(pmol/U 5' nucleotidase activity)  2.6  8.5  3.3 
Lysosomes 
NA/~G activity (U)  918  842 
Cholesterol 
(pmol/U NA/3G activity)  8.5  18.4  2.2 
567  494 
17.5  17.3 
11.2  9.6 
110  400  3.6 
1,995  1,981 
3.9  13.7  3.5 
2,077  1,044 
5.9  41.7  7.1 
Cells were grown according to format 3. On day 3, monolayers  were refed 15 ml of medium C (-LDL) or medium C plus 25 #g/ml LDL (+LDL). Cells were 
harvested after 14 h.  Percoll gradient fractionation  of normal and NPC posmuclear supernatants  was carried out as described in Materials  and Methods. The 
cholesterol content of postnuclear supernatants,  lysosome, and  light membrane  Percoll gradient fractions  was determined by gas-liquid chromatography  as 
described in Materials and Methods. Protein content, NA[3G and 5' nucleotidase  activities of posmuclear superoatants,  and light membrane and lysosomal Percoll 
gradient fractions  were determined as described in Materials  and Methods. The fold increase (b/a) represents the ratio of the cholesterol content in  +LDL (b) 
and  -LDL (a)  samples. 
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LDL- and Mevalonate-dependent Growth of Normal 
and NPC l~broblasts 
Mammalian cells require an exogenous source of cholesterol 
when cultured in the presence of mevinolin, an inhibitor of 
mevalonate synthesis, and thus, cholesterol biosynthesis (7, 
24). The ability of LDL-derived cholesterol to reverse mevin- 
olin-inhibited cell growth was examined in normal and NPC 
fibroblasts (Fig.  1 A). Cell monolayers were grown in me- 
dium B or medium B containing 20/zM mevinolin, 0.15 mM 
mevalonate, and varying concentrations of LDL (Fig. 1 A). 
Mevalonate, at 0.15 mM, is sufficient to supply essential non- 
sterol isoprenoid products (such as ubiquinone and dolichol), 
but the low concentration of mevalonate is not converted to 
cholesterol in sufficient amounts to support the  sterol re- 
quirements of the cells (7, 12, 14). After 8 d, the protein con- 
tent of the wells was measured as an indication of cell growth, 
The protein content in wells of normal fibroblasts cultured 
in medium B was 44 #g/well. When normal fibroblasts were 
cultured in medium B containing 20/zM mevinolin and 0.15 
mM mevalonate, growth was inhibited, and the wells con- 
tained 0.2/~g of protein. The addition of LDL to mevinolin- 
inhibited  ceils  increased  cell  growth  in  a  concentration- 
dependent manner;  normal cells cultured with  mevinolin 
plus 2.5-3.1  #g/ml  LDL grew to the  same level as unin- 
hibited cells (Fig. 1 A). The protein content in wells of NPC 
fibroblasts grown in medium B and medium B containing 20 
#M mevinolin and 0.15 mM mevalonate was 43 and 0.5/zg 
of  protein  per  well,  respectively. Although  uninhibited 
growth rates were the same for both cell types, LDL-choles- 
terol was less effective at reversing the mevinolin-inhibited 
growth of NPC cells. 
Cultured mammalian cells will also grow in the presence 
of mevinolin if supplied with high concentrations of exoge- 
nous mevalonate (24). Mevalonate is taken up by ceils and 
used as substrate for de novo cholesterol synthesis. Mono- 
layers were cultured in medium B or medium B containing 
20/zM mevinolin and varying concentrations of mevalonate 
(Fig. 1 B). We observed that mevalonate restored cell growth 
equally in normal and NPC fibroblasts. This result indicates 
that newly synthesized cholesterol is capable of supporting 
the growth of normal and NPC ceils equally. 
Movement of LDL-derived and Endogenously 
Synthesized Cholesterol to the Plasma Membrane 
in Normal and NPC Cells 
The intracellular transport of LDL-derived [3H]cholesterol 
from lysosomes to plasma membranes was examined using 
[3H-CL]LDL (13).  [3H-CL]LDL binds to the LDL receptor 
and is internalized and delivered to lysosomes where hy- 
drolysis releases [3H]cholesterol. We documented the time 
course of movement of LDL-derived [3H]cholesterol from 
lysosomes to plasma membranes by determining the amount 
of [3H]cholesterol that desorbs from the cells and appears 
in the media during chase incubations.  Chase incubations 
were  performed in  media  containing  SUVs  to  insure  an 
adequate trap for the desorbed cellular [3H]cholesterol (10, 
28, 3O). 
The appearance of [3H]cholesterol in the media is most 
likely the result of either the desorption of plasma membrane 
[3H]cholesterol and its trapping by phospholipid vesicles in 
the medium, or the secretion of lysosomal contents. Evi- 
dence that supports the former is as follows. First, the ap- 
pearance of both LDL-derived and endogenously sythesized 
[3H]cholesterol  in  the  medium  was  dependent  upon  the 
presence ofphospholipid vesicles. Control experiments were 
performed using lipoprotein-deficient serum delipidated by 
the Cab-o-sil method (21), and a time-dependent increase in 
medium [3H]cholesterol was not observed in the absence of 
SUVs (data not shown). The current experiments were per- 
formed in medium containing serum in which lipoproteins 
were  removed by ultracentrifugation,  and  [3H]cholesterol 
does appear in the medium without the addition of SUVs, 
presumably because of the presence of phospholipids and/or 
phospholipid/protein acceptors in the serum. Second, we did 
not observe a  time-dependent increase in  [3H]cholesteryl 
ester in the medium, which would have resulted from a se- 
cretion of lysosomal contents (data not shown).  For these 
reasons,  we think that the  source of medium  [3H]choles- 
terol is the plasma membrane. 
We have included SUVs in our experiments to provide a 
50 
40 
30 
o 
A LDL  B Mevalonate  50' 
mal  4o 
~P  30,  J~  NPC 
7  C  20  ./~'/<  Normal 
t 
LDL (gg/ml)  Mevalonate  (mM) 
Figure 1. Reversal of mevinolin- 
inhibited cell growth by LDL (A) 
and mevalonate (B) in normal (I) 
and  NPC  (D)  fibrohlasts. Cells 
were grown according to format 
1. On day 1, each monolayer re- 
ceived 1.5 ml of medium B (A,zx) 
or medium B containing 20 #M 
mevinolin and 0.15 mM meval- 
onate plus the indicated concen- 
tration of LDL (,4) or additional 
mevalonate (B) (t,~). On day 8, 
monolayers were washed, and the 
protein content of each well was 
measured as described in Mate- 
rials and Methods. Each data point 
represents the average  of  two wells. 
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The SUVs  were prepared with a cholesterol/phosphatidyl- 
choline molar ratio similar to that of purified plasma mem- 
branes (9) to insure that SUV incubation did not deplete cel- 
lular cholesterol levels. 
Normal and NPC monolayers were pulsed with [3H-CL]- 
LDL for 2  h, washed and subjected to chase incubations. 
Cell-associated  [3H]cholesteryl esters,  [3H]cholesterol and 
media [3H]cholesterol were quantitated.  Normal and NPC 
cells  pulsed  for 2  h  with  [3H-CL]LDL (0-h  chase)  con- 
rained  26  and  53  nmol/mg  of cell-associated  [3H]choles- 
teryl esters, respectively (Fig. 2 A). We often found that LDL 
receptor activity was higher in NPC cells. During the chase, 
cell-associated [~H]cholesteryl esters were hydrolyzed with 
the same relative rates in both cell lines. Thus, the amount 
of cell-associated [3H]cholesterol increased with time pro- 
portional to the  amount of cellular  [3H]cholesteryl esters 
(Fig. 2 B). After 8 h of chase, normal and NPC cells con- 
mined 19 and 48 nmol/mg of [3H]cholesterol, respectively. 
Although  normal  cells  had  a  smaller  cellular  pool  of 
[3H]cholesteryl ester and [3H]cholesterol, the rate at which 
[3H]cholesterol appeared in the media was faster in normal 
than in NPC cells. During 8 h of chase, normal and NPC 
cells desorbed 2.0 and  1.1 nmol/mg of [3H]cholesterol, re- 
spectively (Fig. 2 C). To correct for differences in the specific 
activity of the intracellular cholesterol due to increased uptake 
of [3H-CL]LDL by NPC cells, we expressed the amount of 
[3H]cholesterol in the media as a percentage of the sum of 
the cellular [3H]cholesteryl ester plus  [3H]cholesterol and 
medium  [3H]cholesterol (Fig.  2  D).  The data normalized 
for  pool  sizes  indicates  that  8.2%  of the  LDL-derived 
[3H]cholesterol in normal cells was desorbed into the me- 
dium, while only 1.8 % was desorbed from NPC ce.lls during 
8 h of chase. These data suggest that LDL-derived [3H]cho- 
lesterol is produced equivalently in normal and NPC fibro- 
blasts, but movement of  the LDL cholesterol from lysosomes 
to plasma membranes is less efficient in NPC ceils. 
We studied the desorption of endogenously synthesized 
[3H]cholesterol to ascertain whether NPC fibroblasts have a 
general defect in intracellular cholesterol transport or exhibit 
defective desorption of plasma membrane cholesterol. Nor- 
real and NPC monolayers were pulsed for 2 h with [3H]ace- 
tate that is biosynthetically  incorporated into cellular [3H]cho- 
lesterol, then chased with fresh media. Cellular and media 
[3H]cholesterol were quantitated.  After the 2-h pulse, nor- 
mal and NPC cells had 270 and 531  pmol/mg of cellular 
[3H]cholesterol, respectively (Fig.  3 A).  Similar to the in- 
creased LDL receptor activity noted above, a greater rate of 
cholesterol biosynthesis was evident in NPC cells. The level 
of cellular [3H]cholesterol remained relatively constant in 
both cells lines during the chase incubations.  [3H]Choles- 
terol appeared in the media of normal and NPC cells in a 
time-dependent manner (Fig. 3 B). Normal and NPC cells 
desorbed 249 and 400 pmol/mg of pH]cholesterol during 
8 h of chase, respectively. When the amount of [3H]choles- 
terol in the medium was expressed as a percentage of  the total 
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Figure 2. Movement of LDL- 
derived  cholesterol  to  the 
plasma membrane in normal 
(n) and NPC (ra) fibroblasts. 
Cells  were  grown according 
to format 2.  On day 4, each 
monolayer  received I ml of me- 
dium C plus 20 t*M mevino- 
lin,  1 /~g/ml 58-035, and  30 
#g/ml  [3H-CL]LDL.  After 
2 h, monolayers were washed 
and refed with 1 ml of  medium 
C containing 50 #1 SUVs. The 
media were removed after var- 
ious  times,  and  the  cellular 
[3H]cholesteryl  ester (A), eel- 
lular [3H]cholesterol  (B), and 
medium  [3I-I]cholesterol (C) 
contents were determined as 
described  in  Materials  and 
Methods.  In D,  the medium 
[3H]cholesterol  is  expressed 
as  a  percentage of the  total 
cellular  pH]cholesteryl  ester 
and  [3H]cholesterol and  me- 
dium  pH]cholesterol  at each 
time  point.  Each  data  point 
represents the average of  three 
wells. 
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Figure 3. Movement of endogenously synthesized cholesterol to the plasma membrane in normal (m) and NPC (D) fibroblasts. Cells were 
grown according to format 2 in the same experiment as described in Fig 2. On day 4, each monolayer received 1 ml of medium C plus 
15 #Ci/ml  [3H]acetate. After 2 h, monolayers were washed and refed with 1 ml of medium C containing 50 #1 SUVs. The media were 
removed after various times, and the [3H]cholesterol content of cells (A) and media (B) were determined as described in Materials and 
Methods. In C, the [3H]cholesterol  in the medium is expressed as a percentage of the total cellular [3H]cholesterol  and medium [3H]cho- 
lesterol at each time point. Each data point represents the average of three wells. 
pH]cholesterol, we observed that the desorption of endog- 
enously synthesized [3H]cholesterol was identical in normal 
and NPC cells (Fig. 3 C). 
We observed that the levels of [3H]cholesterol increased 
substantially in the media, without a corresponding decrease 
in cellular levels of [3H]cholesterol. This may be because of 
continued synthesis of [3H]cholesterol during the chase in- 
cubation. In subsequent experiments in which mevinolin was 
included  in  the  chase  media,  we  observed that  cellular 
[3H]cholesterol declined reciprocally with increased media 
[3H]cholesterol (data not shown). 
These transport experiments provide only relative rates of 
intracellular  cholesterol movement for the  two  fibroblast 
lines. It is not possible to derive information on the absolute 
kinetics  of  intracellular  [3H]cholesterol movement using 
this protocol, because the cholesterol exhange rate between 
cellular membranes and lipid vesicles is slow compared to 
the reported transport rates of endogenously derived cho- 
lesterol (11, 19).  No experiments have reported the intra- 
cellular movement of exogenously derived cholesterol. We 
observed that the rate of appearance of  endogenously synthe- 
sized [3H]cholesterol in the media was considerably faster 
than that of LDL-derived [3H]cholesterol. This result may 
reflect differences in the rate of intracellular movement of 
cholesterol from its site of synthesis to the plasma membrane 
versus the movement from the lysosomes to the plasma mem- 
brane. 
We noted a fourfold difference in the initial rate of appear- 
ance of LDL-[3H]cholesterol in the media from normal and 
NPC  cells.  This difference gains significance when com- 
pared to the identical rate of appearance of acetate-derived 
[3H]cholesterol in the media of both cell types. The results 
with endogenously synthesized cholesterol provide an im- 
portant control for potential differences in the rate of desorp- 
tion of cholesterol from plasma membranes of normal and 
NPC cells. That is,  if the delayed appearance of LDL-de- 
rived [3H]cholesterol  in the media of NPC cells was because 
of impaired desorption of plasma membrane cholesterol, we 
would expect that the appearance of acetate-derived [3H]cho- 
lesterol would also be impaired. As a further control, SUVs 
containing a nonexchangeable marker, [3H]cholesteryl hexa- 
decyl ether  (29),  were  incubated with  monolayers under 
identical conditions as the above experiment to determine 
whether SUVs were internalized or fused with the cells. Af- 
ter 8 h of incubation, <1% of the [3H]cholesteryl hexadecyl 
ether was cell-associated in both normal and NPC cells (data 
not shown). 
We  next questioned whether  the  defective intracellular 
transport of LDL-derived cholesterol is unique to the NPC 
phenotype  by  performing  cholesterol  desorption  experi- 
ments (identical to those shown in Figs. 2 and 3) with nor- 
mal, NPC, and NPA fibroblasts. Once again, we found that 
LDL-derived [3H]cholesterol appeared threefold slower in 
the media of NPC compared to normal fibroblasts; however, 
NPA  ceils  desorbed  LDL-derived  [3H]cholesterol at  the 
same  rate as  normal cells  (data not shown).  [3H]Choles- 
terol,  biosynthetically formed from [3H]acetate,  appeared 
in the media of normal, NPC, and NPA cells with the same 
time course (data not shown). 
IntraceUular Movement of  LDL-derived Cholesterol 
in Pulse-labeled Normal and NPC Fibroblasts 
We have presented evidence that the  movement of LDL- 
cholesterol from lysosomes to plasma  membranes  is  im- 
paired in NPC fibroblasts. If the movement of LDL-choles- 
terol is diminished while the rate of LDL-cholesteryl ester 
hydrolysis is normal, LDL-cholesterol may accumulate at an 
intracellular site along the transport pathway to the plasma 
membrane in NPC  cells.  Is  LDL-derived cholesterol ac- 
cumulating in NPC lysosomes, as was suggested by the fluo- 
rescence microscopy studies  of Pentchev and  co-workers 
(32)? We used Percoll density gradients to fraetionate fibro- 
blast extracts and separate lysosomes from other subcellular 
organelles, and to follow the time course of movement of 
LDL-derived [3H]cholesterol within cells. 
Normal and NPC fibroblasts were pulsed with [3H-CL]- 
LDL for 1 h, after which cells were washed and chased in 
fresh medium for various times. Normal and NPC cells con- 
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ters after the 1-h pulse, respectively (Fig. 4 A). During the 
chase, the [3H]cholesteryl esters were hydrolyzed, and [3H]- 
cholesterol accumulated in the cells (Fig. 4 B). LDL-derived 
[3H]cholesterol  appeared in the media in a time-dependent 
manner (Fig. 4 C). The chase incubations in this experiment 
were performed in the absence of SUVs. Nonetheless, the 
presence of cholesterol acceptors in the serum was sufficient 
to observe that the appearance of LDL-[3H]cholesterol in 
the media of NPC cells lagged behind that of normal cells 
despite the greater content of pH]cholesterol in NPC cells. 
Posmuclear supematants of cell homogenates were fraction- 
ated on Percoll gradients. The distribution of  marker enzyme 
activities in the normal and NPC gradient fractions is shown 
in Fig. 5. Fig. 5 A shows the density profile of a reference 
Percoll gradient. Fig. 5, B and C, show the gradient profile 
of NA/3G and 5' nucleotidase activities, respectively, from 
extracts of normal and NPC cells harvested at 0-h chase in 
the experiment depicted in Fig. 4. Approximately 41% and 
73 % of the NABG and 5' nucleotidase activities applied to 
the gradient was recovered in the gradient fractions (average 
of 8 experiments). NA/3G activity exhibited a bimodal distri- 
bution, appearing at the bottom of the gradient (fractions 
8-10) as well as the top of the gradient (fractions I-3). We 
observed that the NA/3G activity sedimenting at the bottom 
of the gradient was latent (required detergent during the as- 
say), while the NABG activity at the top of  the gradient (frac- 
tions 1-3) was not latent and probably represents release of 
soluble  enzyme  following  lysosomal  breakage  (data  not 
shown).  The majority of the 5' nucleotidase activity was 
found in the top fractions of the gradient that we have termed 
the light membrane fractions. In preliminary experiments, 
we determined that the light membrane fractions also contain 
enzyme markers for Golgi complex (galactosyl transferase) 
and endoplasmic reticulum (3-hydroxy-3-methylglutaryl  co- 
enzyme A reductase) (data not shown). A cytosolic marker 
enzyme, lactate dehydrogenase, was found in fractions 1 and 
2 (data not shown). 
The distribution of LDL-derived [3H]cholesterol  in gra- 
dient fractions of normal and NPC fibroblasts after various 
chase times is shown in Fig. 6. The [3H]cholesterol  content 
of the entire gradient for each chase incubation is shown to 
emphasize that LDL-[3H]cholesterol was found in the same 
bimodal distribution in normal and NPC cells; i.e., [3H]cho- 
lesterol appears in lysosomes (fractions 9-10) and light mem- 
branes (fractions 2-3). Appreciable amounts of [3H]choles- 
terol are not observed in fraction 1, which contains cytosol. 
The time course of appearance of LDL-[3H]cholesterol in 
gradient fractions revealed marked differences between the 
two cell lines (Fig. 6). In normal cells, [3H]cholesterol  ap- 
peared initially (0 h of chase) in the lysosomes and peaked 
by 2 h. The amount of [3H]eholesterol  increased in the light 
membrane fractions reaching a maximum by 4 h.  At 8 h, 
[3H]cholesterol  in  the  lysosomes had  decreased  substan- 
tially. The  [3H]cholesterol  content of the light membrane 
fraction declined as [3H]cholesterol  appeared in the media 
(Fig. 4 C). In NPC cells, the LDL-derived pH]cholesterol 
content in lysosomes reached a level threefold higher than 
the level observed in normal lysosomes. During subsequent 
chase incubations, the appearance of pH]cholesterol in the 
light membrane fractions of NPC cells was slower than that 
observed in normal cells. 
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Figure  4.  Time course  of [3H-CL]LDL metabolism in  pulse- 
labeled normal (=) and NPC ([]) fibmblasts. Cells were grown ac- 
cording to format 3. On day 4, monolayers were pulse labeled at 
staggered times with [3H-CL]LDL (5 /~g/ml, 1 h).  Monolayers 
were washed, and chase incubations initiated by the addition of 15 
ml of medium C. All dishes were harvested at the same time. Post- 
nuclear supernatants  were fractionated on Percoll density gradients 
as described in Materials and Methods. The analysis of Percoll gra- 
dient fractions is illustrated in Figs. 5-7. The content of cellular 
[3H]cholesteryl ester (A), cellular [3H]cholesterol (B),  and me- 
dium [3H]cholesterol (C)  were determined as described in Cell 
Fractionation Assays in Materials and Methods. Each data point 
represents the value from one dish. 
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Figure 5. Characterization of Percoll gradient fractions of extracts 
of normal (m) and NPC (D) fibroblasts. PercoU gradient fraction- 
ation of normal (u) and NPC (t2) postnuclear supernatants in the 
experiment described in Fig. 4  was carded out as described in 
Materials and Methods. A shows the density profile of the reference 
Percoll gradient. B shows the distribution of NABG activity in gra- 
dient fractions from the 0-h chase normal (m) and NPC  (n) ex- 
tracts. C shows the distribution of 5' nucleotidase activity in gra- 
dient  fractions  from  the  0-h  chase  normal  (=)  and  NPC  ([]) 
extracts. Density and enzyme activities were measured as described 
in Materials and Methods. Enzyme activities are expressed as a 
percentage of the total enzyme activity in each gradient. Each data 
point (A) or vertical bar (B and C) represent the value from one 
gradient fraction. 
as described in Materials and Methods. The [3H]cholesterol  con- 
tent of each gradient fraction was determined in Cell Fractionation 
Assays in Materials and Methods. Each vertical bar represents the 
value from one gradient fraction. 
These data are replotted in Fig. 7 to illustrate the flux of 
[3H]cholesterol  from  lysosomes  to  light  membrane  frac- 
tions. The [3H]cholesterol content of normal and NPC lyso- 
somes  (pooled  fractions  9-10  from  Fig.  6)  after  various 
chase times is shown in Fig. 7 A. The LDL-[3H]cholesterol 
content was the same in lysosomes of normal and NPC cells 
harvested  at 0  time.  By  2  h  of chase,  the  [3H]cholesterol 
content of normal  lysosomes increased slightly, while the 
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Figure 7. Content of [3H]cholesterol in lyso- 
somal (A) and light membrane (B) Percoll gra- 
dient fractions of pulse-labeled normal (10 and 
NPC (n) fibroblasts. Percoll gradient fraction- 
ation of normal (B) and NPC (n) postnuclear 
supernatants in  the  experiment described  in 
Fig. 4 was carded out as described in Mate- 
rials and Methods. The [3H]cholesterol  content 
of gradient fractions with high NA~G activity 
(fractions 9-10) were summed (Lysosomes, A). 
The [3H]cholesterol content of gradient frac- 
tions with high 5' nucleotidase activity (frac- 
tions 2-3) were summed (Light Membranes, 
B). Each data point represents the sum of the 
[3H]cholesterol  in  the  designated  fractions 
from one gradient. 
[3H]cholesterol content of NPC  lysosomes increased dra- 
matically to levels threefold higher than normal.  [3H]Cho- 
lesterol levels then decline in normal and NPC lysosomes 
with the same apparent rates, reaching half maximal levels 
after 5 and 6 h, respectively. A much larger fraction of the 
pH]cholesterol was  retained by the NPC  lysosomes. The 
[3H]cholesterol  content of normal and NPC light membranes 
(pooled fractions 2-3 from Fig.  6) after the chase incuba- 
tions is shown in Fig.  7 B.  The [3H]cholesterol content in 
light membranes of normal cells reached a maximum be- 
tween 2-4 h of chase, whereas the [3H]cholesterol content 
of light membranes in NPC cells did not reach a maximum 
until 8 h of chase. 
These data indicate that LDL-derived [3H]cholesterol ac- 
cumulates to a greater extent in NPC lysosomes (Fig. 7 A). 
Thus, the transfer of LDL-cholesterol to cellular organelles 
that comprise the light membrane fractions is  delayed in 
NPC cells when compared to normal cells (Fig. 7 B). To ac- 
count for differential homogenization and recovery, we nor- 
malized  the  pH]cholesterol content of pooled  lysosomes 
and light membranes for units of NA/~G and 5' nucleotidase 
enzyme activities, respectively, and for protein content in the 
postnuclear supernatants. The results were qualitatively the 
same as those illustrated in Fig. 7; i.e., LDL-cholesterol ac- 
cumulated to a greater extent in lysosomes and was delayed 
in movement to other membranes  of NPC  cells (data not 
shown). 
lntracellular Movement of  LDL-derived Cholesterol in 
Continuously Labeled Normal and NPC Fibroblasts 
The steady-state accumulation of LDL-derived [3H]choles- 
terol in normal and NPC lysosomes was revealed when cells 
were continuously labeled with [3H-CL]LDL and processed 
as described above in the pulse-chase experiment. 
Normal and NPC cells exhibited a similar time-dependent 
increase in total cellular [all]cholesterol content (Fig. 8 A). 
pH]Cholesterol  levels  in  lysosomes  increased  with  the 
same initial rate, and reached steady-state levels that were 
2.5-fold higher in NPC than normal lysosomes (Fig. 8 B). 
The data  suggest that  levels of lysosomal  [3H]cholesterol 
reached steady state at '~8 h in both cell types. The appear- 
ance  of [3H]cholesterol in  light  membrane  fractions  was 
delayed in NPC cells as compared to normal cells (Fig. 8 C). 
However, after a 4-h lag, the rate of appearance of pH]cho- 
lesterol in light membranes was comparable in normal and 
NPC cells. 
The results of the pulse chase and continuous label experi- 
ments concur with the observation that LDL-derived choles- 
terol  accumulates  in  NPC  lysosomes and  that  the  initial 
movement of LDL-derived cholesterol to other cellular mem- 
branes is delayed in NPC fibroblasts. 
LDL-inducecl Increase in Cholesterol Content in 
Normal and NPC Subcellular Fractions 
Normal and NPC monolayers were incubated in the absence 
or presence of 25 #g/ml LDL for 14 h, after which the ceils 
were washed, harvested, and homogenized. Postnuclear su- 
pernatants were fractionated on Percoll gradients to separate 
lysosomes from light membranes.  Aliquots of postnuclear 
supernatants, light membrane, and lysosomal fractions were 
analyzed for cholesterol and protein content and marker en- 
zyme activities. Cholesterol content in light membranes and 
lysosomes was normalized for 5' nucleotidase and NABG ac- 
tivities, respectively, to account for recovery of membranes 
from the Percoll fractions. These data are shown in Table I. 
The cholesterol content of postnuclear supernatants de- 
rived from normal and NPC cells cultured in the absence of 
LDL was identical. As previously reported (27), NPC fibro- 
blasts accumulated more unesterified cholesterol when in- 
cubated with LDL. LDL induced a 2.2- and 3.6-fold increase 
in the cholesterol content of  normal and NPC postnuclear su- 
pernatants, respectively. The LDL-induced overaccumulation 
of cholesterol in NPC cells was not apparent in the choles- 
terol content of the light membrane fractions. LDL incuba- 
tion caused a similar increase in light membrane cholesterol 
for both normal and NPC cells. The cholesterol content of 
lysosomes from normal and NPC cells cultured in the ab- 
sence of LDL was  not  significantly different; however,  a 
striking difference was seen in the lysosomal cholesterol con- 
tent of cells incubated in the presence of LDL. When in- 
cubated with LDL, NPC fibroblasts accumulated three times 
more cholesterol in lysosomes compared to normal cells. 
Discussion 
NPC disease is characterized by a  substantial intracellular 
accumulation of unesterified cholesterol (6). We and Pent- 
chev and colleagues have sought to explain the accumulation 
of unesterified cholesterol in NPC cells. We have found that 
LDL binding and internalization (21, 26), and lysosomal hy- 
drolysis of LDL-cholesteryl esters (21) are normal in NPC 
cells.  However,  LDL  does  not  stimulate  cholesterol es- 
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Figure 8.  Cellular  [3H]cholesterol content  (A)  and  content  of 
[3H]cholesterol in lysosomal (B) and light membrane (C) Percoll 
gradient fractions of continuously labeled normal (,,)  and NPC 
([]) fibroblasts. Cells were grown according to format 3. On day 5, 
monolayers were pulsed at staggered times with [3I-I~CL]LDL  (2 
#g/ml). All dishes were harvested at the same time. Percoll gradient 
fractionation of normal (ll) and NPC (t~) postnuclear supernatants 
was carried out as described in Materials and Methods. The content 
of cellular [3H]cholesterol  (A) was determined as described in Cell 
Fractionation Assays in Materials and Methods. Each data point 
represents the value of one dish. The [3H]cholesterol content of 
gradient fractions with high NA/3G activity (fractions 8-10) were 
summed (Lysosomes, B). The [3H]cholesterol content of gradient 
fractions with high 5' nucleotidase activity (fractions 2-4) were 
summed (Light Membranes, C). Each data point represents the sum 
of the [3H]cholesterol in the designated fractions from one gra- 
dient. 
terification in NPC cells (21, 25). Although LDL does medi- 
ate suppression of cellular cholesterol synthesis and LDL 
receptor activity, these responses occur 0nly after a  pro- 
longed time lag in NPC cells (21, 27).  The accumulation of 
unesterified cholesterol in NPC cells cultured with LDL ap- 
pears to result from an inability of LDL to stimulate choles- 
terol esterification in addition to the lag in LDL-mediated 
down regulation of LDL receptor activity and cellular cho- 
lesterol synthesis. The defect in NPC appears to be specific 
for LDL, since nonlipoprotein effectors, such as 25-hydroxy- 
cholesterol and mevalonate, do elicit normal regulatory re- 
sponses in NPC cells (21). However, the defective regulation 
may also extend to other sources of exogenous cholesterol 
which may enter cells via a lysosomal pathway (25). 
There are several possible explanations for impaired LDL- 
mediated regulation of cholesterol metabolism in NPC cells. 
First, the transport of LDL-derived cholesterol from lyso- 
somes to intracellular regulatory sites may be defective. Sec- 
ond, LDL-derived cholesterol might normally regulate cel- 
lular cholesterol metabolism by further metabolism of the 
unesterified cholesterol to a regulatory sterol. The NPC mu- 
tation may prevent the metabolic conversion of LDL-derived 
cholesterol to this putative regulatory sterol. Third, LDL- 
derived cholesterol may regulate cellular cholesterol metab- 
olism via a second messenger, which may be compromised 
in NPC cells. 
Four lines of evidence indicate that NPC cells express a 
defect in intracellular transport of LDL-derived cholesterol. 
First, we find that mevinolin-inhibited NPC cells are ineffi- 
ient in using LDL-cholesterol for growth. However, exoge- 
nously added mevalonate restores cell growth equally in nor- 
mal and NPC cells. Thus, the inability of cholesterol to fulfill 
growth  requirements in  NPC  cells  is  restricted to  LDL- 
derived cholesterol. This may reflect impaired movement of 
LDL-derived cholesterol from lysosomes to cell membranes. 
Although recent progress has been made in elucidating the 
kinetics and mechanism of movement of newly synthesized 
cholesterol from the endoplasmic reticulum to the plasma 
membrane (17, 19, 20), the mechanism and pathway of intra- 
cellular transport of LDL-cholesterol remains unknown. 
Second, we determined the relative rate of movement of 
LDL-cholesterol to the plasma  membrane in  normal and 
NPC cells by measuring the amount of LDL-derived [3HI- 
cholesterol that appears in the media. The results indicate 
that LDL-derived cholesterol is transported to the plasma 
membrane slower in NPC than in normal cells. NPC cells do 
not exhibit a general defect in intracellular cholesterol trans- 
port since [3H]acetate-derived cholesterol desorbs normally 
in NPC  cells.  In addition,  mevalonate-derived cholesterol 
fulfills growth requirements normally in NPC cells. Third, 
subcellular fractionation of [3H-CL]LDL-Iabeled cells shows 
that, in NPC cells, LDL-cholesterol accumulates to higher 
levels in lysosomes and its movement to other cell membranes 
is delayed. 
Fourth,  cholesterol content data  was  needed to resolve 
whether the retention of LDL-cholesterol in NPC lysosomes 
was due to either a smaller cholesterol pool in lysosomes of 
NPC cells grown in lipoprotein-deficient serum-containing 
media,  or to defective transport of LDL-cholesterol from 
NPC lysosomes. The data in Table I indicate that the latter 
may explain LDL-cholesterol retention in NPC lysosomes. 
We find that the cholesterol content of normal and NPC lyso- 
The Journal of Cell Biology, Volume  108, 1989  1634 somes are equivalent when cells are cultured in lipoprotein- 
deficient serum. However,  incubation with LDL invokes a 
much greater  increase  in  cholesterol mass  in  NPC  lyso- 
somes. 
The cholesterol transport studies are consistent with the 
biochemical analyses that reveal a  delayed time course of 
LDL-mediated regulation of cholesterol synthesis and LDL 
receptor activity in NPC cells (21, 27). That is, in NPC cells, 
the impaired movement of LDL-cholesterol may explain the 
extended time lag seen in LDL-mediated regulation of these 
two activities. However, the cholesterol transport studies are 
inconsistent with the decided block in the ability of LDL to 
stimulate cholesterol esterification (21, 25).  Impaired lipo- 
protein-mediated regulation of cellular cholesterol metabo- 
lism was also reported by Tabas et al. (33-35) in comparative 
studies using two macrophage cell lines incubated with na- 
tive or modified LDL. Tabas'  results  suggest that macro- 
phage cell lines may employ different cholesterol transport 
routes depending on the lipoprotein source. 
As predicted from earlier studies on LDL metabolism (for 
review,  see reference 8),  we note that unesterified, LDL- 
derived cholesterol initially appears in lysosomes. During 
continuous exposure to LDL, the lysosomal content of LDL- 
cholesterol plateaus coincident with the initial appearance of 
LDL-cholesterol in the light membrane fractions. The pla- 
teau is indicative of a steady state in which the production 
of unesterified cholesterol in the lysosomes (by continual 
receptor-mediated endocytosis and hydrolysis of LDL) is 
balanced by the movement of LDL-cholesterol out of the 
lysosomes.  We  believe that the  use  of [3H-CL]LDL and 
subeellular fractionation will prove useful in studying LDL- 
cholesterol movement in a variety of systems. 
Evidence of cholesterol overaccumulation in NPC lyso- 
somes was first indicated by fluorescence microscopy. Kruth 
et al.  (18) used filipin to detect unesterified cholesterol in 
normal and NPC fibroblasts. In NPC cells incubated with 
LDL,  unesterified  cholesterol  was  found  to  accumulate 
within spherical inclusions with a perinuclear distribution 
similar to that of lysosomes. In a later study, filipin staining 
of LDL-incubated NPC ceils was shown to colocalize with 
indirect immunochemical staining of a lysosomal membrane 
protein (32). These studies did not discern the source of cho- 
lesterol accumulating in lysosomes of LDL-incubated cells. 
Pentchev and coworkers also used Percoll gradients to de- 
termine the site of cholesterol accumulation in NPC fibro- 
blasts cultured with LDL (27). They found that, in normal 
and NPC cells incubated in the absence of LDL, unesterified 
cholesterol mass colocalized with light membranes that con- 
tained plasma membrane and Golgi complex marker en- 
zymes. Incubation with 50/~g/ml LDL for 48 h did not alter 
the cholesterol distribution in normal or NPC cells. How- 
ever,  in LDL-incubated NPC ceils, there was a substantial 
redistribution of the  lysosomal marker  enzyme that now 
largely colocalized with cholesterol-containing, light mem- 
brane fractions. These "light lysosomes" may be the con- 
sequence of prolonged incubation of NPC cells with high 
concentrations of LDL. An excessive accumulation of cho- 
lesterol in NPC lysosomes could result in decreased buoyant 
density of the organelle. We do not observe a density shift 
in lysosomal enzyme activity in NPC cells incubated with 
LDL for two possible reasons. First, we incubated cells with 
a  relatively low concentration of LDL (10-25  #g/ml) for 
short incubation periods (1-20 h). These milder conditions 
were similar to those used for the LDL-mediated regulation 
studies of normal and NPC cells (21). Second, our Percoll 
gradients were formed using a lower Percoll starting density. 
In our hands, the higher concentrations of Percoll that are 
routinely used to isolate lysosomes (23, 31) did not separate 
lysosomes from other subcellular organelles. Consequently, 
our Percoll gradients may not separate light and heavy lyso- 
somes. Pentchev concluded that, in NPC cells, LDL incuba- 
tion causes excess unesterified sterol to accumulate in the 
light lysosome-light membrane region of the Percoll gradient 
(27). In our experiments, we are able to differentiate between 
lysosomes and light membranes. Most importantly, the use 
of pH-CL]LDL allows us to measure the accumulation of 
LDL-[3H]cholesterol, specifically, in NPC lysosomes. 
A  defect in cholesterol transport in NPC cells was also 
deduced from experiments that utilized cholesterol oxidase 
to measure levels of  plasma membrane cholesterol (32). This 
report did not address whether the defect encompassed the 
transport of newly synthesized and/or LDL-derived choles- 
terol. Our results complement those of Sokol et al. (32) and 
extend the observation to show that endogenously synthe- 
sized cholesterol is transported normally, while LDL-cho- 
lesterol transport is defective in NPC cells. 
Blanchette-Mackie et al.  (4) have recently shown, using 
cytochemical techniques,  that NPC cells incubated with LDL 
also accumulate cholesterol in the Golgi complex. They sug- 
gest that components of the Golgi complex may play a role 
in the intracellular movement of  exogenously  derived choles- 
terol, and that impairment of cholesterol movement in the 
Golgi complex may be partly responsible for the defect seen 
in NPC cells. If cholesterol trafficking in the Golgi complex 
is disrupted in NPC cells, one may expect to see impaired 
movement of endogenously derived cholesterol.  Yet,  our 
results indicate that endogenously derived cholesterol moves 
normally in NPC cells. Even if LDL-cholesterol transport is 
impaired in the Golgi complex of NPC  cells,  our results 
could be explained if endogenously synthesized cholesterol 
is not transported through the Golgi complex, or if endoge- 
nously  synthesized and  LDL-derived cholesterol  assume 
different routes through the Golgi complex stacks. 
The defect in intracellular cholesterol transport appears to 
be specific for NPC. Experiments to measure the appearance 
of LDL-[3H]cholesterol in the media, as described in Figs. 
2  and 3,  were also conducted with NPA  fibroblasts.  NPA 
cells, exhibiting no detectable lysosomal sphingomyelinase 
activity, were chosen to determine if high lysosomal sphin- 
gomyelin levels could be responsible for the impaired cho- 
lesterol transport seen in NPC cells. Sphingomyelin has a 
higher affinity than other phospholipids for cholesterol (28), 
and in vitro experiments have shown that cholesterol prefer- 
entially partitions  into  sphingomyelin-containing bilayers 
(28).  Nonetheless, we observed that LDL-derived [3H]cho- 
lesterol was transported from lysosomes to plasma mem- 
branes normally in NPA cells (data not shown). This result 
indicates that the accumulation of LDL-cholesterol in NPC 
lysosomes, and the delayed movement of LDL-cholesterol to 
the plasma membrane, is not a result of coaccumulation of 
sphingomyelin in NPC lysosomes. This finding is consistent 
with the report of Pentchev et al. (25) that LDL-stimulated 
cholesterol esterification is normal in NPA cells. 
What causes the accumulation of LDL-derived cholesterol 
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lysosomes because of the presence of either a unique protein 
or lipid, or aberrant levels of a normal lysosomal protein or 
lipid.  A  lysosomal component with the potential to affect 
cholesterol movement is sphingomyelin; however, it is un- 
likely that excess sphingomyelin is the cause,  since LDL- 
cholesterol transport is normal in NPA cells. Once the higher 
cholesterol level is reached in NPC lysosomes, cholesterol 
appears  to leave NPC and normal lysosomes with similar 
rates (see Figs. 7 A and 8 B). This raises the possibility that 
cholesterol must fill a larger pool in NPC lysosomes, after 
which the rate of exit is normal. The regulation studies (21, 
27) also show that NPC cells exhibit a prolonged lag phase 
beyond which LDL-mediated suppression of cholesterol syn- 
thesis and LDL receptor activity proceeds with normal time 
courses. Alternatively,  NPC cells may be expressing defec- 
tive extralysosomal components, such as carder proteins or 
lipids, or specific vesicular/micellar elements that may medi- 
ate intracellular  cholesterol transport. 
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